FDA•MODERATE
Kirkland Signature Ultra Strength Antacid
Guardian Drug is recalling Kirkland Signature Ultra Strength Antacid tablets due to potential metallic particle contamination.
23 productsFilters
Category
Agency
Severity
Drugs Recalls
Back to home ←
FDA•MODERATEDuloxetine DR Capsules 30 mgAsclemed USA is recalling Duloxetine DR Capsules 30 mg due to the presence of a nitrosamine impurity above acceptable intake limits.
FDA•MODERATEEstradiol Gel 0.1% PacketsANI Pharmaceuticals is recalling Estradiol Gel 0.1% packets due to a defective container issue resulting in empty or partially full packets.
FDA•MODERATEFentanyl Citrate Sterile CADD for InjectionIntegraDose is recalling Fentanyl Citrate Sterile CADD for Injection due to subpotency.
FDA•MODERATELidocaine HCl Injection USPSpectra Medical Devices is recalling Lidocaine HCl Injection USP single-dose ampules due to a lack of assurance of sterility.
FDA•MODERATEGas-X Simethicone 125 mg SoftGelsHaleon is recalling Gas-X Simethicone 125 mg SoftGels (120 count), UPC 3 00674 35041 9, due to incomplete inactive ingredient labeling.
FDA•MODERATECimzia Prefilled SyringesUCB is recalling Cimzia prefilled syringes and starter kits due to a lack of assurance of sterility.
FDA•MODERATEAmlodipine and Olmesartan Medoxomil TabletsAscend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, due to failed dissolution specifications.
FDA•MODERATENephronex Vitamin B-Complex, Vitamin C & Folic Acid LiquidSafecor Health is recalling Nephronex oral liquid supplement due to foreign substance contamination from observed black particles.
FDA•MODERATEOphthavet Ophthalmic SolutionDechra is recalling Ophthavet Ophthalmic Solution for dogs and cats due to a lack of sterility assurance.
FDA•MODERATEAtomoxetine HCl 10mg CapsulesSafecor is recalling Atomoxetine HCl 10mg Capsules (NDC 64380-474-01) because some cartons may contain 25mg capsules due to a labeling error.
- FDA•MODERATEDuloxetine Delayed-Release Capsules 30 mg
Ajanta Pharma is recalling Duloxetine 30 mg capsules due to the presence of an N-nitroso-Duloxetine impurity above recommended safety limits.
3 products 
FDA•MODERATEErythromycin 250 mg TabletsZydus is recalling Erythromycin 250 mg tablets due to the presence of N-Nitroso-Desmethyl-Erythromycin above acceptable intake limits.
2 products
FDA•MODERATEOasis Tears PF Lubricant Eye DropsOasis Tears PF eye drops (NDC 42126-6400-1) recalled due to lack of assurance of sterility.
FDA•MODERATEMetoprolol Succinate Extended-Release Tablets 25 mgAscend Laboratories is recalling 25 mg Metoprolol Succinate Extended-Release Tablets due to failed dissolution testing.
FDA•MODERATEAmoxicillin and Clavulanate Potassium Oral Suspension DropsCronus Pharma is recalling Amoxicillin and Clavulanate Potassium oral suspension drops for dogs and cats due to product discoloration.
2 products
FDA•MODERATEOctreotide Acetate Injectable Suspension 30 mgTeva is recalling Octreotide Acetate 30 mg injectable suspension kits (NDC 0480-9262-08) due to sterility assurance concerns from manufacturing deficiencies.
2 products
FDA•MODERATELiraglutide InjectionLupin is recalling Liraglutide Injection (NDC 70748-346-02 and 70748-346-03) due to white thread-like particulate matter in the cartridge.
FDA•MODERATEiVIZIA Sterile Lubricant Eye DropsThea Pharma is recalling iVIZIA Sterile Lubricant Eye Drops due to a lack of assurance of sterility.
2 products
FDA•MODERATEEnalapril Maleate Tablets, USP 20 mgRising Pharma is recalling Enalapril Maleate 20 mg tablets (NDC 64980-688-10) due to failed impurities test.
FDA•MODERATEBD PurPrep Sterile SolutionCareFusion is recalling BD PurPrep sterile solution distributed nationwide due to potential contamination and lack of sterility assurance.
2 products
FDA•MODERATESystane Lubricant Eye GelAlcon is recalling Systane Lubricant Eye Gel due to a lack of assurance of sterility.
2 products
FDA•MODERATEDuloxetine Delayed-Release Capsules USP 60mgBreckenridge Pharmaceutical recalls Duloxetine 60mg capsules (NDC 51991-748-90) due to elevated N-nitroso impurity from manufacturing deviations.
FDA•MODERATEOptase Dry Eye Intense DropsScope Health is recalling Optase Dry Eye Intense Drops (0.33 fl oz, NDC 72972-002-01) due to lack of assurance of sterility.
FDA•MODERATENaproxen Oral Suspension USP 125 mg/5mLAcella Pharmaceuticals is recalling Naproxen Oral Suspension 125 mg/5mL (NDC 42192-619-16) due to lead and lithium contamination above specification.
FDA•MODERATEFreshKote Lubricant EyedropsHarrow Eye LLC is recalling FreshKote Lubricant Eyedrops (0.33 fl oz) due to lack of assurance of sterility.
FDA•MODERATEOmega-3-Acid Ethyl Esters Capsules 1 gramMajor Pharmaceuticals is recalling Omega-3-Acid Ethyl Esters Capsules 1 gram (NDC 0904-7495-06) due to failed capsule shell specifications.
FDA•MODERATEDesmopressin Nasal Spray, USP 10 mcg/0.1 mLApotex is recalling Desmopressin Nasal Spray (NDC 60505-0815-0) due to defective bottle caps with missing or dislodged liners.
3 products
FDA•MODERATEAlendronate Sodium Oral Solution 70 mg/75 mLHikma is recalling Alendronate Sodium Oral Solution 70 mg/75 mL (NDC 0054-0282-59) due to out-of-specification assay results.
FDA•MODERATEClaravis (isotretinoin capsule, USP) 10 mgTeva is recalling Claravis 10 mg capsules (NDC 0555-1054-56, 0555-1054-86) due to out-of-specification Tretinoin impurity levels.
3 products
FDA•MODERATEDelflex Peritoneal Dialysis SolutionFresenius Medical Care is recalling Delflex Peritoneal Dialysis Solution due to potential bag leaks and a lack of sterility assurance.
2 products
FDA•MODERATESterile Water for Injection USPB. Braun is recalling 3000 mL Sterile Water for Injection USP bags distributed nationwide due to potential sterility and leakage issues.
4 products
FDA•MODERATELidocaine HCl Injection 1%Huons is recalling Lidocaine HCl injection 1% 5 mL vials distributed nationwide due to a lack of assurance of sterility.
9 products
FDA•MODERATEEpinephrine Injection USP 1 mg/10mLInternational Medication Systems is recalling Epinephrine Injection 1 mg/10mL (NDC 76329-3318-1) due to lack of sterility assurance.
FDA•MODERATESkin Script Blemish Spot TreatmentSkin Script Blemish Spot Treatment recalled over failed stability specifications; UPC 6 10563 13873 9.
FDA•MODERATEPhenylephrine Hydrochloride Injectable SolutionWells Pharma is recalling Phenylephrine Hydrochloride Injectable Solution (40mg, 250mL) distributed nationwide due to cGMP deviations.
7 products
FDA•MODERATEPrazosin Hydrochloride Capsules 1mgAppco Pharma is recalling Prazosin Hydrochloride 1mg capsules due to the presence of N-nitroso-prazosin (NNP) impurity above acceptable limits.
3 products
FDA•MODERATEPantoprazole Sodium Delayed-Release Tablets 40 mgCamber Pharmaceuticals is recalling Pantoprazole Sodium 40 mg tablets (NDC 31722-713-10) due to discoloration.
FDA•MODERATEGeri-Care Artificial Tears Lubricant Eye DropsGeri-Care Artificial Tears Lubricant Eye Drops (0.5 oz, NDC 68788-7266-0) recalled due to lack of sterility assurance.
FDA•MODERATEFluocinonide 0.05% CreamTaro Pharmaceuticals is recalling Fluocinonide 0.05% Cream due to out-of-specification viscosity results.
3 products
FDA•MODERATEOmnipaque (iohexol) InjectionGE Healthcare is recalling Omnipaque (iohexol) injection due to the presence of particulate matter.
2 products
FDA•MODERATEMemantine Hydrochloride Extended-Release 7 mg CapsulesMajor Pharmaceuticals is recalling Memantine Hydrochloride Extended-Release 7 mg capsules (NDC 0904-6734-61) due to failed dissolution specifications.
FDA•MODERATEVancomycin HCl InjectionFagron is recalling Vancomycin HCl 1.5g/250mL injections distributed nationwide due to sterility concerns and potential port detachment.
5 products
FDA•MODERATEExchange Select Honey Lemon Cough DropsExchange Select Honey Lemon Cough Drops are being recalled due to manufacturing quality concerns.
15 products
FDA•MODERATEFurosemide Tablets, USP 80 mgLeading Pharma is recalling Furosemide Tablets 80 mg (NDC 69315-118-01) due to N-nitroso-Furosemide above recommended limits.
FDA•MODERATETramadol Hydrochloride Tablets, USP 50 mgAmneal is recalling tramadol 50 mg tablets (NDC 60219-2348-5) due to elevated N-nitroso-desmethyl-tramadol impurity.
FDA•MODERATEClonidine Transdermal System 0.2 mg/dayTeva Pharmaceuticals is recalling Clonidine Transdermal System 0.2 mg/day due to the use of an unapproved raw material during manufacturing.
3 products
FDA•MODERATEBromfenac Ophthalmic Solution 0.07%Alembic Pharmaceuticals is recalling Bromfenac Ophthalmic Solution 0.07% (NDC 62332-583-03) due to failed impurities and degradation specifications.
FDA•MODERATEOctreotide Acetate for Injectable SuspensionTeva is recalling Octreotide Acetate for Injectable Suspension due to a lack of assurance of sterility.
6 products
FDA•MODERATECurosurf (poractant alfa) 240 mg Intratracheal SuspensionChiesi USA is recalling Curosurf 240 mg intratracheal suspension vials (NDC 10122-510-03) due to lack of sterility assurance.